LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 119 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $84 | -74.2% | 58,300 | -60.2% | 0.00% | – |
| Q1 2024 | $326 | -36.1% | 146,541 | -44.3% | 0.00% | – |
| Q4 2023 | $510 | +40.9% | 263,070 | +7.3% | 0.00% | – |
| Q3 2023 | $362 | -42.5% | 245,243 | +23.7% | 0.00% | – |
| Q2 2023 | $630 | +8.8% | 198,268 | -19.2% | 0.00% | – |
| Q1 2023 | $579 | -50.3% | 245,251 | -26.9% | 0.00% | -100.0% |
| Q4 2022 | $1,164 | -99.9% | 335,408 | +149.0% | 0.00% | 0.0% |
| Q3 2022 | $988,000 | +1633.3% | 134,708 | +1451.2% | 0.00% | – |
| Q2 2022 | $57,000 | -65.2% | 8,684 | -73.4% | 0.00% | – |
| Q1 2022 | $164,000 | – | 32,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WuXi AppTec Co., Ltd. | 7,682,156 | $11,139,126 | 47.74% |
| MWG Management Ltd. | 20,162,332 | $29,235,381 | 31.93% |
| Orland Properties Ltd | 15,093,969 | $21,886,255 | 16.63% |
| Foresite Capital Management IV, LLC | 8,325,000 | $12,071,250 | 8.11% |
| Opaleye Management Inc. | 1,670,000 | $2,421,500 | 0.55% |
| MIC Capital Management UK LLP | 1,740,569 | $2,523,825 | 0.55% |
| Alphabet Inc. | 5,865,125 | $8,504,431 | 0.43% |
| HSG Holding Ltd | 3,045,997 | $4,995,435 | 0.18% |
| Orbimed Advisors | 6,405,098 | $9,287,392 | 0.18% |
| Ikarian Capital, LLC | 526,066 | $762,796 | 0.13% |